Code | CSB-AP000881HU |
MSDS | |
Size | $354 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
Discover the potential of our Recombinant Human CCL7 protein, an indispensable tool for researchers in immunology. This C-C motif chemokine 7, also known as CCL7, MCP3, SCYA6, and SCYA7, is expressed in E. coli and comprises the 24-99aa expression region of the full-length mature protein. The tag-free protein is provided as a lyophilized powder, ensuring straightforward reconstitution with sterile water or buffer for various experimental uses.
Quality is of utmost importance to us, and our Recombinant Human CCL7 protein demonstrates a purity of >97% as determined by SDS-PAGE and HPLC analysis. Endotoxin levels are kept below 1.0 EU/µg, as assessed by the LAL method. The protein exhibits full biological activity in a chemotaxis bioassay using human monocytes, with an effective concentration range of 10-100 ng/ml.
Recent investigations have explored the role of CCL7 in immune system regulation and its involvement in numerous pathologies, including inflammatory diseases[1], autoimmune diseases[2], and cancer[3]. The versatile functions of CCL7 in the immune system emphasize its importance as a research target and its potential therapeutic applications.
References:
1. Proost P, et al. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. J Immunol. 1996;156(6): 2079-85.
2. Weber C, et al. MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells. Int J Cancer. 2002;99(6): 923-7.
3. Wang L, et al. The C-C motif chemokine ligand 7 and interferon γ play an important role in the development of focal and segmental glomerulosclerosis. Ann Transl Med. 2020;8(6): 388.
There are currently no reviews for this product.